Elsevier, The American Journal of Pathology, 2(181), p. 376-379, 2012
DOI: 10.1016/j.ajpath.2012.06.006
Full text: Download
In 1994, The American Journal of Pathology published a key article reporting that hypoxic retina produces vascular endothelial growth factor (VEGF), suggesting a role for VEGF in ocular neovascularization. Subsequent developments in anti-VEGF treatment for neovascular eye disease have improved visual outcomes and changed the standard of care in retinal medicine and ophthalmology.